Community Fundraising January Wrap-Up
7 February 2020
The first month of the year is over already and the time has come again to recognise the incredible work of our community fundraisers. Throughout January our community created, hosted and participated in some amazing events, each of them helping us on our quest to reach zero deaths from melanoma.
You might remember Jenny Keck and her Bayview Country Picnic from our #fundraiserfriday late last year. Just before Christmas in 2018, Jenny’s daughter-in-law Amanda was diagnosed with melanoma. Jenny hosts a backyard music festival every January to raise money for a worthy cause and this year, the backyard music festival raised $1411 for MIA! Big thanks to Jenny, Amanda and MIA's Speakers Hub speaker Kristy Roberts for helping make the day a huge success.
The staff at Bub’s Famous Fish & Chips in Nelson Bay wore specially designed Game On Mole shirts throughout the month of January to promote melanoma awareness and their fundraising initiative where $1 from every fish and chips sold was donated to MIA. A big shout out to Joanne Howarth and her team at Bub's who will keep us updated on the fundraising total.
The Maudsland Market in QLD chose MIA as the beneficiary of its monthly charity raffle in January. Along with the usual range of fresh produce, plants and other goodies, they raised $270 for MIA and raise awareness about melanoma. Thank you to Adrienne English and all who participated!
Another of our wonderful community fundraisers you may have seen highlighted on #fundraiserfriday is Renee Marchment. She completed her 6to6 swim at Crescent Aquatic Centre in Crescent Head. Renee took on the challenge to swim from 6 pm to 6 am to help raise awareness about melanoma as well as funds for MIA. Not only did Renee raise over $16,500 for melanoma research, but she was named ‘Citizen of the Year’ in the 2020 Crescent Head Australia Day Awards! Thank you and well done, Renee.
Also on the food theme, Fullerton Health in Cardiff hosted a two-day bake sale to celebrate Australia Day and raise funds for MIA. We thank everyone there, and all our devoted community fundraisers, for their continued support.
Prof Georgina Long has been appointed President-Elect Society for Melanoma Research (SMR).
The Australasian Melanoma Conference is bringing together some of the world's leading researchers and clinicians.
Best practice guidelines for melanoma care have gone digital with the first-ever online guidelines developed to adapt to the rapid change in clinical management.
Congratulations are in order for two of our talented researchers.
Professor Richard Scolyer will be sharing his expertise on melanoma pathology at the upcoming Australasian Melanoma Conference. Here he discusses what he'll be presenting on.
Researchers at MIA have established a High Risk Clinic to monitor people at very high risk of developing melanoma.
A generous donation has enabled a medical oncologist from Portugal to learn from the best in the world at MIA.
MIA is hosting a conference to bring together greats minds in melanoma research that will make a difference to the lives of melanoma patients
Meet Michelle, our Translational Research Officer whose role is to connect the clinics to the lab by ensuring patient blood and tissue samples are documented and carefully stored in our BioSpecimen Bank.
Dr James Wilmott says his Wildfire Award will help expand research into treatment options for people with mucosal melanoma, a rare but deadly form of skin cancer.
Following the recent hype around immunotherapies in cancer, CEO Carole Renouf shares the greatest story never told… resistance… and what MIA is doing to address it.
A/Prof Wargo discusses the research she will be presenting as a keynote speaker at the upcoming Australasian Melanoma Conference.
Dr James Wilmott has been awarded the Wildfire award at this year's Cancer Institute NSW's Premier Awards for Outstanding Cancer Research.
The community has responded generously to our recent appeal to fund a specialised nursing position in an exciting new clinical trial.
We have developed a unique clinical trial that will use existing drugs to target rare genes in melanoma patients.
Data presented at the recent ASCO Annual Meeting showcased advances in melanoma research, particularly long-term survival data.
We value your privacy and want you to be familiar with how we collect, use and disclose your information.
Melanoma Institute Australia has partnered with IBM Research in Australia to help further advance melanoma identification using cognitive technology.
CEO Carole Renouf chats to senior clinicians and researchers as part of our "4 Questions With..." short video series.
MIA's 'Stop the Spread' campaign has been shortlisted in the 2016 Cannes Lions International Festival of Creativity.